Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors | ElmerPress

Skip to navigation Skip to main content

Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors

By Takuma Ohashi et al. Journal of Hematology, Volume 12, Number2, April 2023.

Featured in Famous Databases

PubMed

Clarivate

Scopus

Portico